NO931831L - Farmas!ytiske blandinger - Google Patents

Farmas!ytiske blandinger

Info

Publication number
NO931831L
NO931831L NO931831A NO931831A NO931831L NO 931831 L NO931831 L NO 931831L NO 931831 A NO931831 A NO 931831A NO 931831 A NO931831 A NO 931831A NO 931831 L NO931831 L NO 931831L
Authority
NO
Norway
Prior art keywords
cis
pharmaceutical
pharmaceutical surfactants
surfactants
acitretin
Prior art date
Application number
NO931831A
Other languages
English (en)
Other versions
NO931831D0 (no
Inventor
Werner Bollag
Manfred Brockhaus
Willi Hunziker
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO931831D0 publication Critical patent/NO931831D0/no
Publication of NO931831L publication Critical patent/NO931831L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Farmasøytisk preparat som inneholder 9-cis- eller 13-cis-retinsyre eller acitretin som virkestoffer, et farmasøytisk anvendbart salt eller en ester derav, et vitamin D-derivat og vanlige farmasøytiske bærere.
NO931831A 1992-05-20 1993-05-19 Farmas!ytiske blandinger NO931831L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH161992 1992-05-20
CH92693 1993-03-26

Publications (2)

Publication Number Publication Date
NO931831D0 NO931831D0 (no) 1993-05-19
NO931831L true NO931831L (no) 1993-11-22

Family

ID=25686129

Family Applications (1)

Application Number Title Priority Date Filing Date
NO931831A NO931831L (no) 1992-05-20 1993-05-19 Farmas!ytiske blandinger

Country Status (12)

Country Link
EP (1) EP0579915A1 (no)
JP (1) JPH0632740A (no)
KR (1) KR940005278A (no)
CN (1) CN1080525A (no)
AU (1) AU3716193A (no)
CA (1) CA2096196A1 (no)
CZ (1) CZ83293A3 (no)
HU (1) HUT66864A (no)
IL (1) IL105700A0 (no)
NO (1) NO931831L (no)
NZ (1) NZ247630A (no)
TW (1) TW272187B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461622B2 (en) * 1994-09-07 2002-10-08 Johnson & Johnson Consumer Companies, Inc. Topical compositions
DK128494A (da) * 1994-11-08 1996-05-09 Edel K Seidenschnur Behandling af keratinøse og psoriatiske sygdomstilstande med neglelak indeholdende vitamin D metabolit, eller derivat, og/eller vitamin A derivat
US5837728A (en) * 1995-01-27 1998-11-17 Molecular Design International 9-cis retinoic acid esters and amides and uses thereof
AU6944796A (en) * 1995-09-28 1997-04-17 Teijin Limited Preventive or remedy for hyperthyreosis
US5716946A (en) * 1996-02-13 1998-02-10 Wisconsin Alumni Research Foundation Multiple sclerosis treatment
DK0815858T3 (da) * 1996-07-01 2001-10-08 Nisshin Flour Milling Co Farmaceutisk præparat, der indeholder 9-cis-retinsyre-alfa-tocopherolester, til behandling af leukæmi
US5891865A (en) * 1996-10-04 1999-04-06 Wisconsin Alumni Research Foundation Treatment of arthritic disease induced by infectious agents
FR2767058B1 (fr) * 1997-08-05 2000-05-05 Centre Nat Rech Scient Utilisation d'un compose de type retinoide, notamment l'acide retinoique pour la preparation d' un medicament destine au traitement de l'obesite.
US8541469B2 (en) 1997-08-23 2013-09-24 Glaxo Group Limited Treatment of cell-mediated immune diseases
EP0908179A1 (en) 1997-08-23 1999-04-14 Werner Bollag Treatment of cell-mediated immune diseases
US20010002396A1 (en) * 1998-07-16 2001-05-31 Charles Achkar Compositions and methods of treating skin conditions
US6552009B2 (en) 1998-07-16 2003-04-22 Gentrix Llc Compositions and methods of treating abnormal cell proliferation
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6479474B2 (en) 1999-07-08 2002-11-12 Wisconsin Alumni Research Foundation Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
US6733779B2 (en) * 1999-08-26 2004-05-11 L. Dean Parks Method of treating benign prostatic hyperplasia and other benign prostate conditions
FR2807662A1 (fr) * 2000-04-12 2001-10-19 Cll Pharma Procede pour stabiliser la granulometrie d'un principe actif verulent disperse dans un liquide et ses applications
US6339107B1 (en) 2000-08-02 2002-01-15 Syntex (U.S.A.) Llc Methods for treatment of Emphysema using 13-cis retinoic acid
JP2002104995A (ja) * 2000-09-29 2002-04-10 Masahiko Hosaka テロメラーゼ活性抑制剤
JP4326159B2 (ja) 2001-02-09 2009-09-02 株式会社ジェイテクト 玉軸受
WO2004098612A2 (en) * 2003-05-07 2004-11-18 Ab Science Calcitriol analogs of uses thereof
US20070099996A1 (en) * 2003-05-20 2007-05-03 Shashikanth Isloor Pharmaceutical compositions of acitretin
WO2005102296A2 (en) * 2004-04-23 2005-11-03 Heptagen Limited Combinations for the treatment of immunoproliferative skin disorders such as psoriasis
CN102727476B (zh) * 2012-06-14 2014-05-14 合肥博太医药生物技术发展有限公司 视黄酸及其衍生物在制备防治骨质疏松药物中的应用
JP2019014676A (ja) * 2017-07-06 2019-01-31 東海カプセル株式会社 カプセル剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6360910A (ja) * 1986-09-01 1988-03-17 Shiseido Co Ltd 皮膚外用剤

Also Published As

Publication number Publication date
CN1080525A (zh) 1994-01-12
NZ247630A (en) 1995-12-21
IL105700A0 (en) 1993-09-22
NO931831D0 (no) 1993-05-19
KR940005278A (ko) 1994-03-21
AU3716193A (en) 1993-11-25
HU9301404D0 (en) 1993-09-28
JPH0632740A (ja) 1994-02-08
EP0579915A1 (de) 1994-01-26
HUT66864A (en) 1995-01-30
TW272187B (no) 1996-03-11
CZ83293A3 (en) 1993-12-15
CA2096196A1 (en) 1993-11-21

Similar Documents

Publication Publication Date Title
NO931831L (no) Farmas!ytiske blandinger
DE3669104D1 (de) Pharmazeutische praeparate, die ascorbinsaeurederivate enthalten.
DK0497794T3 (da) Mikroperoxidasepræparat indeholdende et hemopeptid som en aktiv bestanddel
NO933854L (no) Promedikamenter, deres fremstilling og anvendelse som legemiddel
MY100721A (en) Therapeutic agent.
NL187352C (nl) Farmaceutisch preparaat, alsmede sulfonzuurester van een 2-oxoalkanol derivaat.
NO943888L (no) Farmasöytisk preparat
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
AU601957B2 (en) Immunostimulant agents
BR8604535A (pt) Composicao inseticida compreendendo mais que um ingrediente ativo
NO973017D0 (no) Nye trienoiske retinoid forbindelser og fremgangsmåter
DE59300688D1 (de) Tablette mit verbesserter Bioverfügbarkeit enthaltend Dichlormethylendiphosphonsäure als Wirkstoff.
DE69915487D1 (de) Erythromycin-derivate mit antibiotischer wirkung
ES2141978T3 (es) Retinoides triciclicos, metodos para su produccion y uso.
HUT51105A (en) Pesticide comprising substituted acrylic acid ester derivatives as active ingredient and process for producing the active ingredients
AU5643686A (en) Novel carboxylic acid esters, methods for production thereof and insecticides containing them as the active ingredient
NO950950L (no) Farmasöytisk preparat
NO940844D0 (no) Farmasöytisk aktive hydroksykarboksylsyrederivater
FI962264A (fi) Tulehduksia aiheuttavan sytokiinin muodostumisen inhibiittori, joka käsittää polyprenyylin johdannaisia aktiivisena ainesosana
DK0804927T3 (da) Multiantioxidantholdigt medikament
DK0876367T3 (da) Trans apovincaminsyreesterderivater som lægemidler
IL108246A (en) (all-e)-3,7-dimethyl-9-(3, 5-dimethyl- 2-nonyloxyphenyl)-2, 4, 6, 8-nonatetraenoic acid derivatives, their preparation and pharmaceutical compositions containing them
MX9201482A (es) Acidos carboxilicos opticamente activos, proceso para su preparacion y composiciones farmaceuticas que los contienen.
RU93049320A (ru) Фармацевтические композиции
NO920050L (no) Trifluormetyl-1-karba(1-detia)cefemer